deltatrials
Completed PHASE4 INTERVENTIONAL 4-arm NCT03537196

DRug Use & Infections in ViEtnam - Hepatitis C (DRIVE-C) (DRIVE-C)

Towards HCV Elimination: Evaluation of an Integrated Model of HCV Care Targeting People Who Inject Drugs in Hai Phong, Vietnam

Sponsor: ANRS, Emerging Infectious Diseases

Conditions Drug Use Hepatitis C Viral Hepatitis C
Interventions Ribavirin Sofosbuvir 400 mg and Daclatasvir 60 mg Sofosbuvir 400 mg and Daclatasvir 90 mg Sofosbuvir and Daclatasvir for 24 weeks
Updated 14 times since 2018 Last updated: Oct 25, 2023 Started: Nov 13, 2018 Primary completion: Nov 30, 2020 Completion: Dec 30, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Drug Use and Hepatitis C, this trial is completed. The trial is conducted by ANRS, Emerging Infectious Diseases and has accumulated 14 data snapshots since 2018. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

~Jun 2018 – ~Oct 2018 · 4 months · monthly snapshot~Oct 2018 – ~Dec 2018 · 2 months · monthly snapshot~Dec 2018 – ~Apr 2020 · 16 months · monthly snapshot~Apr 2020 – ~Jul 2020 · 3 months · monthly snapshot~Jul 2020 – ~Sep 2020 · 2 months · monthly snapshot~Sep 2020 – ~Jan 2021 · 4 months · monthly snapshot~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshot~Feb 2021 – ~Oct 2021 · 8 months · monthly snapshot~Oct 2021 – ~Sep 2023 · 23 months · monthly snapshot~Sep 2023 – ~Nov 2023 · 2 months · monthly snapshot~Nov 2023 – ~Jul 2024 · 8 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 11 months · monthly snapshot

Change History

14 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE4

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE4

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  4. Nov 2023 — Jul 2024 [monthly]

    Completed PHASE4

  5. Sep 2023 — Nov 2023 [monthly]

    Completed PHASE4

▶ Show 9 earlier versions

  1. Oct 2021 — Sep 2023 [monthly]

    Completed PHASE4

  2. Feb 2021 — Oct 2021 [monthly]

    Completed PHASE4

    Status: Active Not Recruiting → Completed

  3. Jan 2021 — Feb 2021 [monthly]

    Active Not Recruiting PHASE4

  4. Sep 2020 — Jan 2021 [monthly]

    Active Not Recruiting PHASE4

  5. Jul 2020 — Sep 2020 [monthly]

    Active Not Recruiting PHASE4

  6. Apr 2020 — Jul 2020 [monthly]

    Active Not Recruiting PHASE4

    Status: Enrolling By Invitation → Active Not Recruiting

  7. Dec 2018 — Apr 2020 [monthly]

    Enrolling By Invitation PHASE4

    Status: Not Yet Recruiting → Enrolling By Invitation

  8. Oct 2018 — Dec 2018 [monthly]

    Not Yet Recruiting PHASE4

  9. Jun 2018 — Oct 2018 [monthly]

    Not Yet Recruiting PHASE4

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • ANRS, Emerging Infectious Diseases
Data source: ANRS, Emerging Infectious Diseases

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations